AgNavigator News
-
Saudi start-up Terraxy, a KAUST spinout, has raised $3 million in a Seed-2 round led by Wa’ed Ventures, Aramco’s venture arm, to scale its proprietary soil-regeneration technology for arid environments. The funding will enable Terraxy to move from pilot to industrial scale, including building a commercial facility in Al Zulfi, and deploy its Carbosoil soil enhancer, which claims to boost plant growth and carbon storage in degraded desert soils. The company’s dual focus on productivity and carbon capture aligns with Saudi Arabia’s Vision 2030 and broader sustainability goals, with strong backing from research institutions and regulatory frameworks.
-
Corteva and FMC Corporation are partnering to expand access to a dual-mode-of-action herbicide at a time when the former prepares for a Q4 spin-off and the latter seeks to pay down a $1 billion in debt.
-
The European Parliament has adopted new rules for plants developed using new genomic techniques (NGTs), shifting the EU from process-based to product-based regulation and aligning with models promoted by global agribusiness giants like Bayer, Syngenta, and Corteva. The legislation introduces a two-tier system: NGT-1 plants with changes comparable to conventional breeding will be fast-tracked and treated like traditional crops, while NGT-2 plants with more complex modifications will remain under GMO oversight. Industry groups have welcomed the changes as promoting innovation and competitiveness, but NGOs argue this amounts to deregulation, warning of risks to consumers, farmers, and organic supply chains. As the rules move toward implementation, debate continues over transparency, labelling, and safeguards.
-
Michael Lee of Syngenta Group Ventures examines the mental “algorithms” that guide venture capital investment in agtech, contrasting it with biotech and public markets to highlight the need for disciplined valuations and realistic exit expectations. He argues that agtech’s structurally smaller market, limited buyer pool, and reliance on M&A exits—rather than IPOs—demand conservative valuation assumptions, capital efficiency, and early strategic alignment with potential acquirers. The essay concludes that inflated valuations are harmful, high burn rates often lead to poor outcomes, and investors should focus on realistic exit values and capital discipline to improve agtech investment returns.